Cleerly is a cardiovascular diagnostics company that uses AI-driven analysis of non-invasive coronary imaging to quantify plaque, evaluate stenosis, and assess ischemia. Their platform provides actionable insights for clinicians to personalize heart attack risk assessment and guide treatment decisions, focusing on plaque characterization and CAD evaluation. The company markets solutions for healthcare providers, payors, and patients, with emphasis on whole-heart assessment and imaging-based risk stratification. Headquartered in the United States, Cleerly serves a global medical community through its web-based software and clinical publications and demonstrations.
No recent news for this company.
No recent deals for this company.